Inventor
KOPECKY DAVID JOHN
US21 patents
Patents
21 patentsUS10532042B2Jan 14, 2020
KRAS G12C inhibitors and methods of using the same
AMGEN INC49 citations97
US10519146B2Dec 31, 2019
KRAS G12C inhibitors and methods of using the same
AMGEN INC81 citations97
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US11285135B2Mar 29, 2022
KRAS G12C inhibitors and methods of using the same
AMGEN INC20 citations93
US10221162B2Mar 5, 2019
Triazole agonists of the APJ receptor
AMGEN INC12 citations92
US10058550B2Aug 28, 2018
Methods of treating heart failure
AMGEN INC13 citations92
US9868721B2Jan 16, 2018
Triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9845310B2Dec 19, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9751864B2Sep 5, 2017
Methods for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9745286B2Aug 29, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9656998B2May 23, 2017
Intermediates for preparing triazole agonists of the APJ receptor
AMGEN INC14 citations92
US9656997B2May 23, 2017
Triazole agonists of the APJ receptor
AMGEN INC16 citations92
US9573936B2Feb 21, 2017
Triazole agonists of the APJ receptor
AMGEN INC19 citations92
US11905281B2Feb 20, 2024
KRAS G12C inhibitors and methods of using the same
AMGEN INC13 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US10150760B2Dec 11, 2018
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor
AMGEN INC8 citations84
US9988369B2Jun 5, 2018
Heterocyclic triazole compounds as agonists of the APJ receptor
AMGEN INC8 citations83
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64